RUA Life Sciences plc EBIT

RUA Life Sciences plc (RUA.L) currently reports a EBIT of $-850K as of March 2026. That compares with $-4.2M in the prior-year period — up 80.0% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore RUA Life Sciences plc's EBIT history and peer comparisons.

RUA Life Sciences plc's EBIT increased from $-4.2M to $-850K — a 80.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RUA Life Sciences plc's EBIT of $-850K is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

RUA Life Sciences plc reported $-850K in EBIT as of March 2026. That compares with $-4.2M in the prior-year period — up 80.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-850K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for RUA Life Sciences plc, and consider following RUA.L for alerts when major investors trade the stock.